Invesque (IVQ) AI Stock Analysis

• Market Cap: $109.69M
• Dividend Yield: N/A
• Average Volume (3M): 37.16K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.23
• Revenue Growth: -14.85%
• EPS Growth: 79.75%
• Country: CA
• Employees: 1,448
• Sector: Real Estate
• Sector Strength: 53
• Industry: Real Estate - Services
• EPS (TTM): 0.02
• Shares Outstanding: 914,074,400
• 10 Day Avg. Volume: 27,812
• 30 Day Avg. Volume: 37,165
• PEG Ratio: <0.01
• Price to Book (P/B): 0.04
• Price to Sales (P/S): 0.03
• P/FCF Ratio: 1.11
• Enterprise Value/Market Cap: 3.33
• Enterprise Value/Revenue: 2.51
• Enterprise Value/Gross Profit: 6.80
• Enterprise Value/Ebitda: 9.40
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Sell
• Number of Analyst Covering: 0

• Rating: 40 Underperform
• Price Target: C$0.00 ▼(-100.00% Downside)

Invesque's overall stock score is primarily impacted by its poor financial performance, characterized by declining revenues, negative profitability, and high leverage. Technical analysis indicates a bearish trend, and valuation metrics reflect unprofitability, further lowering the score.

Invesque Business Overview & Revenue Model

Company Description

Invesque Inc. operates as a health care real estate investment company. Its portfolio includes investments in independent living, assisted living, memory care, skilled nursing, transitional care, and medical office properties. As of March 11, 2022, the company owned a portfolio of 88 properties, including 60 assisted living and memory care facilities, 12 skilled nursing facilities, 10 transitional care properties, and 4 medical office buildings in the United States; and 15 properties comprised 11 medical office buildings, and 4 seniors housing and care facilities in Canada. It also includes investments in owner occupied seniors housing properties, which comprise the ownership of real estate properties, as well as provides management services. The company was formerly known as Mainstreet Health Investments Inc. and changed its name to Invesque Inc. in January 2018. Invesque Inc. was incorporated in 2007 and is headquartered in Toronto, Canada.

How the Company Makes Money

Invesque makes money primarily through leasing its portfolio of healthcare properties to operators and tenants in the senior living and healthcare sectors. The company's revenue model is based on rental income generated from these properties. Invesque enters into long-term lease agreements with healthcare operators, which provide stable and predictable cash flow. The company may also engage in property acquisitions and disposals to optimize its portfolio and maximize returns. Additionally, partnerships with healthcare operators and strategic investments in the sector contribute to the company's earnings by enhancing property value and operational efficiency.

Invesque Financial Statement Overview

Summary

Invesque faces significant financial challenges, with declining revenues and profitability, high leverage, and weak cash flow generation. The negative growth rates and high debt levels suggest potential financial instability.

Income Statement

Invesque's income statement shows declining revenue with a negative growth rate of -9.16% TTM, indicating a challenging market environment. The gross profit margin is relatively stable at 38.17%, but the net profit margin is negative at -24.24%, reflecting ongoing profitability issues. The EBIT margin is low at 2.74%, and EBITDA margin is 9.10%, suggesting limited operational efficiency.

Balance Sheet

The balance sheet reveals a high debt-to-equity ratio of 3.44 TTM, indicating significant leverage and potential financial risk. Return on equity is negative at -33.12%, highlighting unprofitable operations. The equity ratio is not explicitly provided, but the high leverage suggests limited equity relative to assets.

Cash Flow

Cash flow analysis shows a concerning decline in free cash flow growth at -242.34% TTM, and operating cash flow is negative, indicating cash management challenges. The operating cash flow to net income ratio is low at 0.02, and free cash flow to net income ratio is 0.46, reflecting weak cash generation relative to earnings.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	145.56M	162.67M	188.75M	198.03M	210.45M	217.39M
Gross Profit	53.69M	59.00M	72.41M	95.59M	90.97M	108.39M
EBITDA	38.85M	24.27M	-18.83M	10.38M	49.13M	-101.52M
Net Income	-7.08M	-36.14M	-99.24M	-42.01M	-28.54M	-184.00M
Balance Sheet
Total Assets	325.57M	637.22M	828.28M	1.10B	1.30B	1.50B
Cash, Cash Equivalents and Short-Term Investments	10.65M	18.16M	10.74M	27.58M	19.37M	34.13M
Total Debt	180.50M	394.84M	588.25M	765.46M	893.75M	1.05B
Total Liabilities	194.00M	518.05M	681.18M	865.69M	1.01B	1.21B
Stockholders Equity	131.57M	119.17M	146.59M	231.65M	286.26M	293.33M
Cash Flow
Free Cash Flow	-5.77M	4.40M	217.00K	5.40M	11.11M	13.82M
Operating Cash Flow	-1.04M	9.27M	6.03M	11.91M	18.68M	25.09M
Investing Cash Flow	324.25M	152.21M	132.05M	137.49M	119.19M	2.98M
Financing Cash Flow	-323.34M	-154.07M	-154.92M	-141.19M	-152.63M	-5.78M

Invesque Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.12
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:IVQ, the sentiment is Positive. The current price of 0.12 is below the 20-day moving average (MA) of 0.12, below the 50-day MA of 0.13, and below the 200-day MA of 0.14, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 56.57 is Neutral, neither overbought nor oversold. The STOCH value of 73.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:IVQ.

Invesque Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IEI	73 Outperform	36.48M	6.30	5.20%	2.07%	0.60%	0.00%
SVI	58 Neutral	1.81B	-58.41	-32.46%	0.24%	7.94%	-12.23%
MPC	56 Neutral	294.82M	18.94	-10.71%	8.25%	8.61%	0.00%
BRE	49 Neutral	143.40M	-7.29	21.32%	9.14%	184.78%	-222.63%
IVQ	40 Underperform	$109.69M	―	-6.06%	―	-14.85%	79.75%
Sector *	65 Neutral	$2.17B	12.19	3.79%	4.94%	3.15%	1.96%

Invesque Corporate Events

Invesque Sells Remaining Nursing Facilities, Boosts Financial Flexibility

Invesque Inc. has completed the sale of its last two skilled nursing facilities in Illinois, using the proceeds to fully repay its KeyBank credit facility. This transaction enhances Invesque’s financial flexibility by freeing up two previously encumbered assets and aligns with its de-levering strategy. The company’s real estate portfolio now comprises 19 assets across eight US states and one Canadian province, marking significant progress in its strategic repositioning.

Invesque Inc. Advances Asset Disposition Strategy in Q2 2025

Invesque Inc. reported significant progress in its asset disposition strategy during the second quarter of 2025, with several sales transactions completed, including the sale of seniors housing assets in New York, Virginia, Pennsylvania, Texas, Indiana, Arkansas, and Michigan. The company used the proceeds to reduce leverage and streamline its capital stack, expecting further debt repayment progress. The transition of management for certain assets is anticipated to stabilize operations and enhance financial results.

Invesque Inc. Sells Seniors Housing Assets and Optimizes Management

Invesque Inc. has completed the sale of eleven seniors housing assets and transitioned management at four other properties, as part of a strategic move to optimize its portfolio. The transactions, which include the sale of properties in New York, Texas, Indiana, Arkansas, and Michigan, are expected to improve financial performance and allow the company to repay debt and potentially return capital to shareholders, enhancing shareholder value.

Invesque Inc. Shareholders Approve Key Resolutions at Annual Meeting

Invesque Inc. announced the results of its annual and special meeting of shareholders, where all nominated directors were elected with overwhelming support. Additionally, the appointment of KPMG LLP as auditors and special business resolutions, including a Sale Resolution and Reduction in Capital Resolution, were approved by a significant majority. These outcomes reflect strong shareholder confidence and support for Invesque’s strategic direction, potentially enhancing its position in the health care real estate market.